Women who go through menopause later in life have healthier blood vessels for years to come than those who go through it earlier, according to new University of Colorado Boulder research.
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...